XPNPEP2 and prostate carcinoma: Using a gene prioritization method (GP-MIDAS-VXEF) to compare prostate cancer and lymph node metastasis, Carlos Roberto Arias et.al demonstrated that XPNPEP2 is a metastatic gene candidate19.